Moderna vs. Stocks Cramer Discussed
This is a news story, published by Yahoo Finance, that relates primarily to Jim Cramer news.
Jim Cramer news
For more Jim Cramer news, you can click here:
more Jim Cramer newsstocks trading & speculation news
For more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
Jim Cramer. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest price targets news, Stocks news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
CramerInsider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
•Business
Business & Economics
Jim Cramer Calls Moderna (MRNA) ‘Problematic’
61% Informative
Jim Cramer recently discussed the bearishness in the stock market during a recent appearance on CNBC ’s Squawk on the Street.
Cramer also shared an interesting trading strategy from his personal life.
He revealed that at the end of every month , he contributes to an S&P fund as he can’t directly buy stocks.
However, while Cramer has stopped buying for himself as of the date the show aired, he did share strategies about when to buy.
Moderna, Inc. (NASDAQ:MRNA) is a biotechnology company whose shares have been unable to catch a break ever since the coronavirus pandemic ended.
The firm’s shares are down by 73% over the past year , and they haven’t caught a break in 2025 either as they have lost 33.8% year-to-date .
MRNA ranks 6th on our list of stocks that Jim Cramer discusses.
VR Score
50
Informative language
39
Neutral language
22
Article tone
informal
Language
English
Language complexity
28
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
6
Source diversity
1
Affiliate links
no affiliate links
Small business owner?